189 related articles for article (PubMed ID: 10374222)
21. The long-term risks and benefits of hormone replacement therapy.
Hillard TC; Whitcroft S; Ellerington MC; Whitehead MI
J Clin Pharm Ther; 1991 Aug; 16(4):231-45. PubMed ID: 1939402
[TBL] [Abstract][Full Text] [Related]
22. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
Whittington R; Faulds D
Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
[TBL] [Abstract][Full Text] [Related]
23. The choice of hormone replacement therapy or statin therapy in the treatment of hyperlipidemic postmenopausal women.
Seed M
Atheroscler Suppl; 2002 May; 3(1):53-63. PubMed ID: 12044587
[TBL] [Abstract][Full Text] [Related]
24. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
Ness J; Aronow WS; Newkirk E; McDanel D
J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
[TBL] [Abstract][Full Text] [Related]
25. Psychological factors influencing cardiovascular risk reduction behavior in low and middle income African-American women.
Walcott-McQuigg JA
J Natl Black Nurses Assoc; 2000 Jan; 11(1):27-35. PubMed ID: 11854949
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy and breast cancer: heterogeneous risks by race, weight, and breast density.
Hou N; Hong S; Wang W; Olopade OI; Dignam JJ; Huo D
J Natl Cancer Inst; 2013 Sep; 105(18):1365-72. PubMed ID: 24003037
[TBL] [Abstract][Full Text] [Related]
27. Hormone replacement therapy awareness in a biracial cohort of women aged 50-54 years.
MacDougall LA; Barzilay JI; Helmick CG
Menopause; 1999; 6(3):251-6. PubMed ID: 10486796
[TBL] [Abstract][Full Text] [Related]
28. Hormone replacement therapy in women treated for gynaecological malignancy.
Burger CW; van Leeuwen FE; Scheele F; Kenemans P
Maturitas; 1999 Jun; 32(2):69-76. PubMed ID: 10465374
[TBL] [Abstract][Full Text] [Related]
29. HRT and the primary prevention of cardiovascular disease.
Stevenson JC
Maturitas; 2007 May; 57(1):31-4. PubMed ID: 17383835
[TBL] [Abstract][Full Text] [Related]
30. Prescription of hormone replacement therapy in postmenopausal women with renal failure.
Stehman-Breen CO; Gillen D; Gipson D
Kidney Int; 1999 Dec; 56(6):2243-7. PubMed ID: 10594801
[TBL] [Abstract][Full Text] [Related]
31. The role of personal health concerns and knowledge of the health effects of hormone replacement therapy (HRT) on the ever use of HRT by menopausal women, aged 50-54 years.
MacDougall LA; Barzilay JI; Helmick CG
J Womens Health Gend Based Med; 1999 Nov; 8(9):1203-11. PubMed ID: 10595334
[TBL] [Abstract][Full Text] [Related]
32. Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
Tackett AH; Bailey AL; Foody JM; Miller JM; Apperson-Hansen C; Ohman EM; Hochman JS; Karnash SL; Califf RM; Topol EJ; Moliterno DJ
Am Heart J; 2010 Oct; 160(4):678-84. PubMed ID: 20934562
[TBL] [Abstract][Full Text] [Related]
33. Educating patients about the benefits and drawbacks of hormone replacement therapy.
Rozenberg S; Vasquez JB; Vandromme J; Kroll M
Drugs Aging; 1998 Jul; 13(1):33-41. PubMed ID: 9679207
[TBL] [Abstract][Full Text] [Related]
34. Severe obesity, heart disease, and death among white, African American, and Hispanic postmenopausal women.
McTigue KM; Chang YF; Eaton C; Garcia L; Johnson KC; Lewis CE; Liu S; Mackey RH; Robinson J; Rosal MC; Snetselaar L; Valoski A; Kuller LH
Obesity (Silver Spring); 2014 Mar; 22(3):801-10. PubMed ID: 24493096
[TBL] [Abstract][Full Text] [Related]
35. Hormone replacement therapy and cardioprotection: the end of the tale?
Rosano GM; Vitale C; Silvestri A; Fini M
Ann N Y Acad Sci; 2003 Nov; 997():351-7. PubMed ID: 14644842
[TBL] [Abstract][Full Text] [Related]
36. Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women.
Gabriel SR; Carmona L; Roque M; Sánchez GL; Bonfill X
Cochrane Database Syst Rev; 2005 Apr; (2):CD002229. PubMed ID: 15846631
[TBL] [Abstract][Full Text] [Related]
37. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
38. Ethnicity and breast cancer: factors influencing differences in incidence and outcome.
Chlebowski RT; Chen Z; Anderson GL; Rohan T; Aragaki A; Lane D; Dolan NC; Paskett ED; McTiernan A; Hubbell FA; Adams-Campbell LL; Prentice R
J Natl Cancer Inst; 2005 Mar; 97(6):439-48. PubMed ID: 15770008
[TBL] [Abstract][Full Text] [Related]
39. Postmenopausal estrogen use among African American and white patients at an urban clinic.
Jahnige K; Fiebach N
J Womens Health; 1997 Feb; 6(1):93-101. PubMed ID: 9065378
[TBL] [Abstract][Full Text] [Related]
40. [Current role of hormone replacement therapy in the prevention of postmenopausal osteoporosis: gynecologic point of view].
Tamborini A; Ruiz JC
Rev Med Interne; 2004 Dec; 25 Suppl 5():S580-7. PubMed ID: 15841951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
